Now live: Pro — the full 13F research suite for serious investorsSee pricing →
FARALLON CAPITAL MANAGEMENT LLC

Q1 2024 · 13F-HR/A

FARALLON CAPITAL MANAGEMENT LLCholdings as filed

Filed 2025-11-14 · accession 0000908834-25-000347

$92.9M
Reported value
1
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
023436108AMEDAMEDISYS INC$92.9M100.0%1,008,300CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.